The Indian oncology drugs market has been growing substantially on account of rise in cancer prevalence, evolving treatment protocol, and widening coverage of healthcare. India, being a country of diverse population and witnessing an increasing incidence of cancer, has emerged as a market of choice for oncology therapies. Recently there have been industry reports that the oncology drugs market in India will grow at a double digit CAGR over the next five years. Rising cancer burden in India and millions of new case diagnosed every year is one of the primary drivers of this growth. The... >>More
Sandhya Sriram, Group CFO, Narayana Health
Ayush Atul Mishra, Co-Founder & CEO, Tattvan E-Clinics
Dr. Archana Dhawan Bajaj, Gynecologist, Obstetrician & IVF Expert, Nurture IVF Clinic
Vinay Jain, Chief Operating Officer, Onelife Nutriscience
Shripad Joshi, President - India & South Asia, Revvity
Dr. Shirish Alurkar, Sr. Consultant- Medical Oncology, HCG Cancer Centre
